Ractopamine

This classification denotes a veterinary beta-adrenergic agonist with the molecular formula C18H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 57370OZ3P1, chemically known as benzenemethanol, 4-hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)- but generally known as ractopamine, which bears US NIH Compound Identifier 56052. European Medicines Agency schedules Ractopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10240MIG. The term RACTOPAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). RACTOPAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ractopamine under HS 29225000 and SITC 51467. As of Q4 2014, RACTOPAMINE remains the US FDA Preferred Term for this commodity. Ractopamine bears US NLM identifiers UMLS ID C0072954 and NCI Concept Code C84132. SMILES: OC(CNC(CCC1CCC(O)CC1)C)C1CCC(O)CC1.